Predictive biomarker of cetuximab res...

Predictive biomarker of cetuximab response incolorectal cancer patients

Posted in the Oncology Forum

Sciclips

Madison, WI

#1 Feb 22, 2012
According to a recent US patent application, serum YKL-40 can be a prognostic biomarker for predicting short overall survival in patients with metastatic colorectal cancer treated with cetuximab. Details: http://www.sciclips.com/sciclips/biomarker-ne...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News New Drug Shows Potential for Blood Cancer Jun 16 Johnwillton 2
News $20M cancer center opens today in Clifton Park Jun 5 Dennis S 1
News Researchers hail new cancer treatment that unlo... Jun '15 Hypothetical 1
News CTCA Oncologist Discusses Cancer Risks Among Mi... May '15 Ms Louisiana 1
News Risk of a calamity if North haze not tackled ur... Apr '15 norman 1
News To Your Good Health: Mental health doctors impo... Apr '15 HumanSpirit 2
News To battle cancer, choose oncologist with care (May '08) Apr '15 VoteJoe 31
More from around the web